In September 2024, a Special Committee of the Board of Directors initiated the Special Committee Investigation through independent legal counsel and independent forensic accountants. During the course of the Special Committee Investigation, the Special Committee discovered accounting and financial reporting errors that required restatement resulting primarily from (i) inaccurate valuation of, and accounting for share-based compensation awards to employees, non-employee directors, and other service providers, and shares issued in exchange for goods and services, (ii) inappropriate capitalization of certain share issuance costs, and (iii) inappropriate accounting for certain convertible notes and warrants issued by the Company. During the course of the Special Committee Investigation, the Special Committee also found that the Company had not properly disclosed certain executive officers, executive compensation and related party transactions. In conjunction with the restatement of the items above, we also made corresponding income tax adjustments to our consolidated financial statements as these balances were impacted by the aforementioned adjustments.

The accounting and financial reporting errors identified as part of the Special Committee Investigation and subsequent restatement preparation are described and summarized as follows:

The valuation and amortization of expense related to stock-based payments to employees and non-employee directors and shares issued to service providers in exchange for goods and services were historically calculated incorrectly. The Company previously accounted for stock-based payments using a grant date fair value that was discounted from the fair value under the incorrect interpretation that the shares were restricted. In addition, the determination of the grant date was incorrectly determined with respect to historically issued stock-based payments. The Company re-evaluated the grant date fair value of stock-based payments under ASC 718. Under ASC 718, the grant date is the date at which the grantor and grantee have a mutual understanding of the key terms and conditions of the stock-based compensation agreement. The Company reviewed all stock-based payment awards to ensure the correct grant date was identified going back to the year ending December 31, 2017. The Company then evaluated the grant date fair value of all stock-based payment awards. The Company used the publicly available closing price of its stock on the date nearest the grant date as this is considered the best indicator of value. Additional expense of $2,422,490 for the years ended March 31, 2017 through 2021 has been recognized in opening retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated period presented.

In the fiscal years ending March 31, 2021 and 2022, the Company incorrectly capitalized costs associated with equity financings. The equity issuance costs did not meet the definition to be capitalized against proceeds. The Company determined that certain capitalized costs should have been expensed as incurred in general and administrative expenses in the consolidated statement of operations. After re-evaluation, the Company determined that the services provided by certain legal and investor relations service providers during financing events did not meet the definition of issuance costs as they were not specific incremental costs that were

directly attributable to the issuance of a debt or equity instrument. The Company recorded an adjustment to reclassify the issuance costs. The adjustment in the year ended March 31, 2021 has been recognized in opening retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated period presented. The adjustment for the year ended March 31, 2022 is reflected as a reclassification from additional paid in capital on the consolidated balance sheet to corporate general and administrative expenses on the consolidated statement of operations.

In the year ended March 31, 2018, the Company issued warrants and the resulting value and recognition of expense for those warrants was accounted for incorrectly. The warrant values were recalculated using a Black-Scholes option pricing model using the relevant inputs based on the terms of the respective warrant. The resulting expense of $606,237 has been reflected in opening retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated period presented.

With respect to warrants issued in December 2021, the Company recorded expense in the periods the warrant vested; however, upon further review, the total warrants were earned upon signing the services agreement. The full value of the warrants issued should have been recorded upon signing of the agreement in December 2021. In conjunction with the restatement, the warrant was re-valued based on the contract date fair value. The impact to the consolidated statement of operations for the year ended March 31, 2022 was $692,099.

Accounting for convertible notes was historically incorrect. Management reviewed all previously issued convertible notes and determined that, historically, conversion options within the convertible note agreements were not accounted for correctly.

As a result of analyzing the convertible notes issued in the year ended March 31, 2019, management determined that a beneficial conversion feature should have been recognized and amortized to interest expense over the term of the convertible notes. The expense would have been fully recognized in periods prior to the restatement and has been recognized in retained earnings on the consolidated balance sheet. In addition, an inducement offer was made to the note holders. After review of the accounting treatment initially recorded, management determined that the fair value of the inducement offer was not calculated correctly. The inducement offer was recalculated by determining the difference between the fair value of all securities and consideration transferred and the fair value of the consideration issuable under the original conversion terms. The resulting expense from the recalculation of the inducement offer has been recognized in retained earnings on the consolidated balance sheet as it occurred in a period prior to the restated periods presented.

Convertible notes and warrants issued in the year ended March 31, 2020 were also evaluated for proper accounting treatment. These convertible notes were not accounted for correctly as the Company did not account for the beneficial conversion feature within the convertible notes and did not allocate the consideration received upon issuance of the notes between the convertible notes and the stock purchase warrants. Under the terms on the convertible note, because the number of shares that would potentially be issued upon conversion were inversely indexed to the price of the Company's Common Stock, the conversion option should have been accounted for separately from the debt host agreement and recorded as a conversion option liability. In addition, the warrants should have been recorded as a liability until the exercise price was set due to the exercise price being indexed to a price upon a future event. In connection with the restatement, the warrants were calculated as a standard forward-start option with unit strike and initial price using a Black-Scholes model assuming constant volatility and rates. The proceeds from the issuance of the convertible notes was then allocated to the conversion option and the warrants at their fair values. The fair values exceeded the total proceeds, therefore no value would have been recorded for the notes and the Company would have recorded a loss on a derivative liability in the year ended March 31, 2020. In the year ended March 31, 2021, when the convertible note matured, the conversion price of the convertible notes as well as the exercise price of the warrants were set. The convertible notes and warrant fair values were calculated as of the date of conversion. The fair value resulted in an additional loss on a derivative liability then the liabilities were reclassified into equity upon conversion. The result of the transactions is accounted for as an adjustment to the opening retained earnings on the consolidated balance sheet.

During the year ended March 31, 2021, the Company entered into a promissory note that was subsequently partially paid by converting a portion of the principal balance into shares of the Company's Common Stock. The extinguishment of debt was recorded incorrectly. Under ASC 470, Debt, an early extinguishment of debt is accounted for by recognizing a gain or loss on the difference between the reacquisition price of the debt and the net carrying amount of the debt. The fair value of the Common Stock issued to extinguish the debt was greater than the principal balance being repaid resulting in a loss on extinguishment. This loss is reflected in the opening retained earnings on the consolidated balance sheet.

The total expense reflected in opening retained earnings on the consolidated balance sheet for all convertible note transactions is $6,024,240.

Historically, the disclosure of related party transactions was omitted or not fully or accurately disclosed in the Company's financial statements. The Company performed an in-depth review and assessment of its related party transactions and the disclosure of such transactions in the affected periods. The Company determined that there were missing related party transaction disclosures which have been included in the related party footnotes (see Note 12, "Notes Payable - Related Party" and Note 18, "Related Party Transactions").

Summary of the Effect of the Restatement of the Company’s Financial Statements

Consolidated Balance Sheets


	As of March 31, 2024
					Adjustments
	As Previously Reported				Stock Based Payments				Equity Issuance Costs				Convertible Notes				Warrants				Acquisition				Other			As Restated
ASSETS
Current assets:
Cash and cash equivalents	$		55,586,441		$	-			$	-			$	-			$	-			$	-			$	-		$	55,586,441
Accounts receivable, net			28,221,321			-				-				-				-				-				-			28,221,321
Inventories			45,563,334			-				-				-				-				-				-			45,563,334
Prepaid expenses			2,154,170			-				-				-				-				-				-			2,154,170
Current portion of restricted cash		-				-				-				-				-				-				-			-
Total current assets			131,525,266				-				-				-				-				-				-		131,525,266

Equipment, net			58,082,040			-				-				-				-				-				-			58,082,040

Other assets:
Deposits			349,278			-				-				-				-				-				-			349,278
Patents, net			4,539,290				-			-				-				-					-				216,716		4,756,006
Other intangible assets, net			111,049,067				-			-				-				-				-				-			111,049,067
Goodwill			90,870,094			-				-				-				-				-				-			90,870,094
Right of use assets - operating leases			2,000,093			-				-				-				-				-				-			2,000,093
Deferred income tax asset			1,487,088			-				-				-				-					-				2,920,403		4,407,491
TOTAL ASSETS	$		399,902,216		$	0			$	0			$	0			$	0			$	0			$	3137119		$	403,039,335

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$		23,156,495		$	-			$	-			$	-			$	-			$	-			$	-		$	23,156,495
Accrued liabilities			7,030,667			-				-				-				-				-					34,777		7,065,444
Current portion of operating lease liability			479,651			-				-				-				-				-				-			479,651
Note payable related party		-				-				-				-				-				-				-			-
Current portion of construction note payable			273,459			-				-				-				-				-				-			273,459
Insurance premium note payable		-				-				-				-				-				-				-			-
Total current liabilities			30,940,272				-				-				-				-				-				34,777.00		30,975,049

Long-term liabilities:
Contingent consideration payable			59,838			-				-				-				-				-				-			59,838
Income tax payable			-			-				-				-				-				-					1,609,520		1,609,520
Construction note payable, net of unamortized issuance costs			10,735,241			-				-				-				-				-				-			10,735,241
Operating lease liability, net of current portion			1,609,836			-				-				-				-				-				-			1,609,836
Deferred income tax liability		-				-				-				-				-					-				-		-
Total liabilities			43,345,187				-				-				-				-				-				1,644,297		44,989,484

Shareholders’ equity:
Series A cumulative perpetual preferred Stock			1,400			-				-				-				-				-				-			1,400
Common stock			119,181				-			-				-				-				-				-			119,181
Additional paid-in capital			396,730,170				13,174,586				7,420,492				6,024,240				1,298,336				5,225,000				653,000		430,525,824
Accumulated deficit			(37,620,566	)			(13,174,586	)			(7,420,492	)			(6,024,240	)			(1,298,336	)			(5,225,000	)			839,822		(69,923,398	)
Treasury stock			(2,673,156	)		-				-				-				-				-				-			(2,673,156	)
Total shareholders’ equity			356,557,029				-				-				-				-				-				1,492,822		358,049,851
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$		399,902,216		$		-		$		-		$		-		$		-		$		-		$		3,137,119	$	403,039,335


	As of March 31, 2023
					Adjustments
	As Previously Reported				Stock Based Payments				Equity Issuance Costs				Convertible Notes				Warrants				Acquisitions				Other				As Restated
ASSETS
Current assets:
Cash and cash equivalents	$		39,134,027		$	-			$	-			$	-			$	-			$	-			$	-			$	39,134,027
Accounts receivable, net			29,346,380			-				-				-				-				-				-				29,346,380
Inventories			54,344,819			-				-				-				-				-				-				54,344,819
Prepaid expenses			5,126,667			-				-				-				-				-				-				5,126,667
Current portion of restricted cash			500,000			-				-				-				-				-				-				500,000
Total current assets			128,451,893				-				-				-				-				-				-			128,451,893

Equipment, net			55,963,255			-				-				-				-				-				-				55,963,255

Other assets:
Deposits			7,028,947			-				-				-				-				-				-				7,028,947
Patents, net			5,032,754				-			-				-				-				-					264,000			5,296,754
Other intangible assets, net			123,726,810				-			-				-				-				-				-				123,726,810
Goodwill			90,870,094			-				-				-				-				-				-				90,870,094
Right of use assets - operating leases			1,261,634			-				-				-				-				-				-				1,261,634
Deferred income tax asset		-				-				-				-				-					-				595,756			595,756
TOTAL ASSETS	$		412,335,387		$		-		$		-		$		-		$		-		$		-		$		859,756		$	413,195,143

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$		18,079,397		$	-			$	-			$	-			$	-			$	-			$	-			$	18,079,397
Accrued liabilities			4,353,354			-				-				-				-				-					34,778			4,388,132
Current portion of operating lease liability			470,734			-				-				-				-				-				-				470,734
Note payable related party			180,850			-				-				-				-				-				-				180,850
Current portion of construction note payable			260,429			-				-				-				-				-				-				260,429
Insurance premium note payable			2,118,635			-				-				-				-				-				-				2,118,635
Total current liabilities			25,463,399				-				-				-				-				-				34,778			25,498,177

Long-term liabilities:
Contingent consideration payable			140,378			-				-				-				-				-				-				140,378
Income tax payable			-			-				-				-				-				-					1,609,520			1,609,520
Construction note payable, net of unamortized issuance costs			10,922,443			-				-				-				-				-				-				10,922,443
Operating lease liability, net of current portion			903,490			-				-				-				-				-				-				903,490
Deferred income tax liability			2,309,592			-				-				-				-				-					(2,309,592	)		-
Total liabilities			39,739,302				-				-				-				-				-				(665,294	)		39,074,008

Shareholders’ equity:
Series A cumulative perpetual preferred Stock			1,400			-				-				-				-				-				-				1,400
Common stock			118,294				-			-				-				-				-				-				118,294
Additional paid-in capital			391,940,374				12,178,405				7,420,492				6,024,240				1,298,336				5,225,000				653,000			424,739,847
Accumulated deficit			(18,941,825	)			(12,178,405	)			(7,420,492	)			(6,024,240	)			(1,298,336	)			(5,225,000	)			872,050			(50,216,248	)
Treasury stock			(522,158	)		-				-				-				-				-				-				(522,158	)
Total shareholders’ equity			372,596,085				-				-				-				-				-				1,525,050			374,121,135
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$		412,335,387		$		-		$		-		$		-		$		-		$		-		$		859,756		$	413,195,143


	As of March 31, 2022
					Adjustments
	As Previously Reported				Stock Based Payments				Equity Issuance Costs				Convertible Notes				Warrants				Acquisition				Other				As Restated
ASSETS
Current assets:
Cash and cash equivalents	$		23,281,475		$	-			$	-			$	-			$	-			$	-			$	-			$	23,281,475
Accounts receivable, net			43,955,084			-				-				-				-				-				-				43,955,084
Due from related parties			15,000																											15,000
Inventories			59,016,152			-				-				-				-				-				-				59,016,152
Prepaid expenses			3,423,925			-				-				-				-				-				-				3,423,925
Current portion of restricted cash			-			-				-				-				-				-				-				-
Total current assets			129,691,636				-				-				-				-				-				-			129,691,636

Equipment, net			37,637,806			-				-				-				-				-				-				37,637,806
																														-
Other assets:																														-
Deposits			11,360,322			-				-				-				-				-				-				11,360,322
Patents, net			5,526,218			-				-				-				-				-					311,284			5,837,502
Other intangible assets, net			136,300,387			-				-				-				-				-				-				136,300,387
Goodwill			90,870,094			-				-				-				-				-				-				90,870,094
Right of use assets - operating leases			2,791,850			-				-				-				-				-				-				2,791,850
Deferred income tax asset		-				-				-				-				-				-					1,350,868			1,350,868
TOTAL ASSETS	$		414,178,313		$		-		$		-		$		-		$		-		$		-		$		1,662,152		$	415,840,465

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$		26,817,083		$	-			$	-			$	-			$	-			$	-			$	-			$	26,817,083
Factoring liability			485,671			-				-				-				-				-				-				485,671
Accrued liabilities			6,178,814			-				-				-				-				-					34,778			6,213,592
Inventory credit facility			825,675			-				-				-				-				-				-				825,675
Current portion of operating lease liability			831,429			-				-				-				-				-				-				831,429
Current portion of note payable related party			684,639			-				-				-				-				-				-				684,639
Total current liabilities			35,823,311				-				-				-				-				-				34,778			35,858,089

Long-term liabilities:
Contingent consideration payable			204,142			-				-				-				-				-				-				204,142
Income tax payable			-			-				-				-				-				-					1,609,520			1,609,520
Notes payable related party, net of current portion			181,132			-				-				-				-				-				-				181,132
Construction note payable, net of unamortized issuance costs			38,330			-				-				-				-				-				-				38,330
Operating lease liability, net of current portion			2,091,351			-				-				-				-				-				-				2,091,351
Deferred income tax liability			1,536,481			-				-				-				-				-					(1,536,481	)		-
Total liabilities			39,874,747				-				-				-				-				-				107,817			39,982,564

Shareholders’ equity:
Series A cumulative perpetual preferred Stock			1,400			-				-				-				-				-				-				1,400
Common stock			116,487			0				-				-				-				-				-				116,487
Additional paid-in capital			385,426,431				8,037,042				7,420,492				6,024,240				1,298,336				5,225,000				653,000			414,084,541
Accumulated deficit			(11,240,752	)			(8,037,042	)			(7,420,492	)			(6,024,240	)			(1,298,336	)			(5,225,000	)			901,335			(38,344,527	)
Treasury stock			-			-				-				-				-				-				-				-
Total shareholders’ equity			374,303,566				-				-				-				-				-				1,554,335			375,857,901
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$		414,178,313		$		-		$		-		$		-		$		-		$		-		$		1,662,152		$	415,840,465

Consolidated Statements of Operations


	Fiscal Year Ended March 31, 2024
				Adjustments
	As Previously Reported			Stock Based Payments			Other			As Restated
Net revenues
Ammunition sales	$	69,390,801		$	-		$	-		$	69,390,801
Marketplace revenue		53,942,076			-			-			53,942,076
Casing sales		21,721,695			-			-			21,721,695
Total revenues		145,054,572			-			-			145,054,572

Cost of revenues		102,431,803			-			47,284			102,479,087
Gross profit		42,622,769			-			(47,284	)		42,575,485

Operating expenses
Selling and marketing		1,370,079			-			-			1,370,079
Corporate general and administrative		29,583,274			-			-			29,583,274
Employee salaries and related expenses		16,703,822			996,180			-			17,700,002
Depreciation and amortization expense		13,542,791			-			-			13,542,791
Total operating expenses		61,199,966			996,180			-			62,196,146
Loss from operations		(18,577,197	)		(996,180	)		(47,284	)		(19,620,661	)

Other expenses
Other income		(332,593	)		-			-			(332,593	)
Interest expense		(446,473	)		-			-			(446,473	)
Total other expense		(779,066	)		-			-			(779,066	)

Loss before income taxes		(19,356,263	)		(996,180	)		(47,284	)		(20,399,727	)

Provision for income taxes		(3,791,063	)		-			(15,055	)		(3,806,118	)

Net loss		(15,565,200	)		(996,180	)		(32,229	)		(16,593,609	)

Preferred stock dividend		(3,122,049	)		-			-			(3,122,049	)

Net loss attributable to common stock shareholders	$	(18,687,249	)	$	(996,180	)	$	(32,229	)	$	(19,715,658	)

Net loss per share
Basic	$	(0.16	)							$	(0.17	)
Diluted	$	(0.16	)							$	(0.17	)


	Fiscal Year Ended March 31, 2023
				Adjustments
	As Previously Reported			Stock Based Payments			Other			As Restated
Net revenues
Ammunition sales	$	114,116,044		$	-		$	-		$	114,116,044
Marketplace revenue		63,149,673			-			-			63,149,673
Casing sales		14,174,084			-			-			14,174,084
Total revenues		191,439,801			-			-			191,439,801

Cost of revenues		136,031,204			-			47,284			136,078,488
Gross profit		55,408,597			-			(47,284	)		55,361,313

Operating expenses
Selling and marketing		4,729,540			-			-			4,729,540
Corporate general and administrative		24,980,079			-			-			24,980,079
Employee salaries and related expenses		15,679,135			4,141,363			-			19,820,498
Depreciation and amortization expense		13,278,762			-			-			13,278,762
Total operating expenses		58,667,516			4,141,363			-			62,808,879
Loss from operations		(3,258,919	)		(4,141,363	)		(47,284	)		(7,447,566	)

Other expenses
Other income		25,181			-			-			25,181
Interest expense		(632,062	)		-			-			(632,062	)
Total other expense		(606,881	)		-			-			(606,881	)

Loss before income taxes		(3,865,800	)		(4,141,363	)		(47,284	)		(8,054,447	)

Provision for income taxes		730,238			-			(17,999	)		712,239

Net loss		(4,596,038	)		(4,141,363	)		(29,285	)		(8,766,686	)

Preferred stock dividend		(3,105,034	)		-			-			(3,105,034	)

Net loss attributable to common stock shareholders	$	(7,701,072	)	$	(4,141,363	)	$	(29,285	)	$	(11,871,720	)

Net loss per share
Basic	$	(0.07	)							$	(0.10	)
Diluted	$	(0.07	)							$	(0.10	)


	Fiscal Year Ended March 31, 2022
				Adjustments
	As Previously Reported			Stock Based Payments			Equity Issuance Costs			Warrants			Other			As Restated
Net revenues
Ammunition sales	$	161,459,025		$	-		$	-		$	-		$	-		$	161,459,025
Marketplace revenue		64,608,516			-			-			-			-			64,608,516
Casing sales		14,201,625			-			-			-			-			14,201,625
Total revenues		240,269,166			-			-			-			-			240,269,166

Cost of revenues		151,505,657			-			-			-			47,284			151,552,941
Gross profit		88,763,509			-			-			-			(47,284	)		88,716,225

Operating expenses
Selling and marketing		7,310,216			-			-			-			-			7,310,216
Corporate general and administrative		16,986,344			3,168			6,438,872			692,099			-			24,120,483
Employee salaries and related expenses		13,615,439			1,418,969			-			-			-			15,034,408
Depreciation and amortization expense		13,702,148			-			-			-			22,917			13,725,065
Total operating expenses		51,614,147			1,422,137			6,438,872			692,099			22,917			60,190,172
Income/(loss) from operations		37,149,362			(1,422,137	)		(6,438,872	)		(692,099	)		(70,201	)		28,526,053

Other expenses
Other income		21,840			-			-			-			-			21,840
Interest expense		(637,797	)		-			-			-			-			(637,797	)
Total other expense		(615,957	)		-			-			-			-			(615,957	)

Income/(loss) before income taxes		36,533,405			(1,422,137	)		(6,438,872	)		(692,099	)		(70,201	)		27,910,096

Provision for income taxes		3,285,969			-			-			-			(1,243,051	)		2,042,918

Net income/(loss)		33,247,436			(1,422,137	)		(6,438,872	)		(692,099	)		1,172,850			25,867,178

Preferred stock dividend		(2,668,649	)		-			-			-			-			(2,668,649	)

Net income/(loss) attributable to common stock shareholders	$	30,578,787		$	(1,422,137	)	$	(6,438,872	)	$	(692,099	)	$	1,172,850		$	23,198,529

Net income/(loss) per share
Basic	$	0.27														$	0.21
Diluted	$	0.27														$	0.20

Consolidated Statements of Stockholders' Equity

The following tables present the Additional Paid-In Capital ("APIC") as previously reported, restatement adjustments and the APIC as restated for the years ended March 31, 2024, 2023 and 2022.



	As Previously Reported		Reclassification			Current Period Adjustment		As Restated

Employee stock awards	$	4,080,170	$	203,000		$	996,181	$	5,279,351
Stock grants		203,000		(203,000	)		-		-



	As Previously Reported		Reclassification			Current Period Adjustment		As Restated

Employee stock awards	$	5,806,003	$	179,094		$	4,141,363	$	10,126,460
Stock grants		179,094		(179,094	)		-		-



	As Previously Reported		Reclassification			Current Period Adjustment		As Restated

Acquisition stock issuances	$	142,691,282	$	-		$	666,372	$	143,357,654
Common stock issued for services and equipment		1,631,701		-			3,854,895		5,486,596
Employee stock awards		5,759,000		252,488			1,417,162		7,428,650
Stock grants		252,488		(252,488	)		-		-
Issuance of Series A Preferred Stock, net of issuance costs		31,008,796		-			1,898,600		32,907,396
Warrants issued for services		1,090,076		-			692,099		1,782,175

Consolidated Statements of Cash Flow


	For the Year Ended March 31, 2024
				Adjustments
	As Previously Reported			Stock Based Payments			Other			As Restated
Cash flows from operating activities:
Net income/(loss)	$	(15,565,200	)	$	(996,180	)	$	(32,229	)	$	(16,593,609	)
Adjustments to reconcile net loss to cash provided by operations:
Depreciation and amortization		18,813,897			-			47,284			18,861,181
Debt discount amortization		83,253			-			-			83,253
Employee stock awards		4,285,108			996,180			-			5,281,288
Common stock purchase options		430,457			-			-			430,457
Contingent consideration payable fair value		(80,540	)		-			-			(80,540	)
Allowance for doubtful accounts		419,527			-			-			419,527
(Gain)/loss on disposal of assets		259,540			-			-			259,540
Reduction in right of use asset		476,252			-			-			476,252
Deferred income taxes		(3,796,680	)		-			(15,055	)		(3,811,735	)
Changes in current assets and liabilities					-			-			-
Accounts receivable		705,532			-			-			705,532
Inventories		8,781,485			-			-			8,781,485
Prepaid expenses		4,028,696			-			-			4,028,696
Deposits		6,679,669			-			-			6,679,669
Accounts payable		5,077,098			-			-			5,077,098
Accrued liabilities		2,532,695			-			-			2,532,695
Operating lease liability		(499,448	)		-			-			(499,448	)
Net cash provided by operating activities		32,631,341			-			-			32,631,341

Cash flows from investing activities:
Purchase of property, plant, and equipment		(8,024,765	)		-			-			(8,024,765	)
Proceeds from disposal of assets		3,750			-			-			3,750
Net cash used in investing activities		(8,021,015	)		-			-			(8,021,015	)

Cash flows from financing activities:
Proceeds from factoring liability		37,252,869			-			-			37,252,869
Payments on factoring liability		(37,252,869	)		-			-			(37,252,869	)
Payments on note payable - related party		(180,850	)		-			-			(180,850	)
Payments on insurance premium note payment		(3,174,834	)		-			-			(3,174,834	)
Payments on construction note payable		(257,425	)		-			-			(257,425	)
Common stock issued for exercised warrants		76,200			-			-			76,200
Preferred stock dividends paid		(2,968,923	)		-			-			(2,968,923	)
Common stock repurchase plan		(2,152,080	)		-			-			(2,152,080	)
Net cash used in financing activities		(8,657,912	)		-			-			(8,657,912	)

Net increase/(decrease) in cash		15,952,414			-			-			15,952,414
Cash, beginning of period		39,134,027			-			-			39,134,027
Restricted cash, beginning of period		500,000			-			-			500,000
Cash and restricted cash, end of period	$	55,586,441		$	-		$	-		$	55,586,441
Restricted cash, end of period	$	-		$	-		$	-		$	-
Cash, end of period	$	55,586,441		$	-		$	-		$	55,586,441


	For the Year Ended March 31, 2023
				Adjustments
	As Previously Reported			Stock Based Payments			Other			As Restated
Cash flows from operating activities:
Net income/(loss)	$	(4,596,038	)	$	(4,141,363	)	$	(29,285	)	$	(8,766,686	)
Adjustments to reconcile net loss to cash provided by operations:
Depreciation and amortization		17,519,949			-			47,284			17,567,233
Debt discount amortization		83,253			-			-			83,253
Employee stock awards		5,986,873			4,141,363			-			10,128,236
Contingent consideration payable fair value		(63,764	)		-			-			(63,764	)
Allowance for doubtful accounts		191,299			-			-			191,299
Reduction in right of use asset		629,140			-			-			629,140
Warrants issued for services		213,819			-			-			213,819
Deferred income taxes		730,238			-			(17,999	)		712,239
Changes in current assets and liabilities
Accounts receivable		14,417,405			-			-			14,417,405
Due to related parties		15,000			-			-			15,000
Inventories		4,671,333			-			-			4,671,333
Prepaid expenses		2,763,855			-			-			2,763,855
Deposits		4,306,375			-			-			4,306,375
Accounts payable		(8,694,813	)		-			-			(8,694,813	)
Accrued liabilities		(1,970,078	)		-			-			(1,970,078	)
Operating lease liability		(647,480	)		-			-			(647,480	)
Net cash provided by operating activities		35,556,366			-			-			35,556,366

Cash flows from investing activities:
Purchase of property, plant, and equipment		(12,541,325	)		-			-			(12,541,325	)
Net cash used in investing activities		(12,541,325	)		-			-			(12,541,325	)

Cash flows from financing activities:
Payments on inventory facility, net		(825,675	)		-			-			(825,675	)
Proceeds from factoring liability		71,348,761			-			-			71,348,761
Payments on factoring liability		(71,834,432	)		-			-			(71,834,432	)
Payments on note payable - related party		(684,921	)		-			-			(684,921	)
Payments on insurance premium note payment		(2,134,143	)		-			-			(2,134,143	)
Proceeds from construction note payable		1,000,000			-			-			1,000,000
Payments on construction note payable		(150,743	)		-			-			(150,743	)
Common stock issued for exercised warrants		101,506			-			-			101,506
Preferred stock dividends paid		(2,960,416	)		-			-			(2,960,416	)
Common stock repurchase plan		(522,426	)		-			-			(522,426	)
Net cash used in financing activities		(6,662,489	)		-			-			(6,662,489	)

Net increase/(decrease) in cash		16,352,552			-			-			16,352,552
Cash, beginning of period		23,281,475			-			-			23,281,475
Restricted cash, beginning of period		-			-			-			-
Cash and restricted cash, end of period	$	39,634,027		$	-		$	-		$	39,634,027
Restricted cash, end of period	$	500,000		$	-		$	-		$	500,000
Cash, end of period	$	39,134,027		$	-		$	-		$	39,134,027


	For the Year Ended March 31, 2022
				Adjustments
	As Previously Reported			Stock Based Payments			Equity Issuance Costs			Warrants			Other			As Restated
Cash flows from operating activities:
Net income/(loss)	$	33,247,436		$	(1,422,137	)	$	(6,438,872	)	$	(692,099	)	$	1,172,850		$	25,867,178
Adjustments to reconcile net loss to cash provided by operations:
Depreciation and amortization		17,339,093			-			-			-			70,201			17,409,294
Debt discount amortization		38,330			-			-			-			-			38,330
Employee stock awards		6,011,488			1,418,969			-			-			-			7,430,457
Stock for services		4,200			3,168			5,352,500			-			-			5,359,868
Contingent consideration payable fair value		(385,750	)		-			-			-			-			(385,750	)
Allowance for doubtful accounts		2,748,250			-			-			-			-			2,748,250
(Gain)/loss on disposal of assets		(12,044	)		-			-			-			-			(12,044	)
Reduction in right of use asset		720,491			-			-			-			-			720,491
Warrants issued for services		718,045			-			-			692,099			-			1,410,144
Deferred income taxes		1,536,481			-			-			-			(1,243,051	)		293,430
Changes in current assets and liabilities
Accounts receivable		(20,707,052	)		-			-			-			-			(20,707,052	)
Due to related parties		657			-			-			-			-			657
Inventories		(43,149,234	)		-			-			-			-			(43,149,234	)
Prepaid expenses		1,996,287			-			-			-			-			1,996,287
Deposits		(8,826,504	)		-			-			-			-			(8,826,504	)
Accounts payable		9,930,191			-			-			-			-			9,930,191
Accrued liabilities		2,374,686			-			-			-			-			2,374,686
Operating lease liability		(732,468	)		-			-			-			-			(732,468	)
Net cash provided by operating activities		2,852,583			-			(1,086,372	)		-			-			1,766,211

Cash flows from investing activities:
Gemini acquisition		(50,517,840	)		-			-			-			-			(50,517,840	)
Purchase of property, plant, and equipment		(19,218,982	)		-			-			-			-			(19,218,982	)
Proceeds from disposal of assets		59,800			-			-			-			-			59,800
Net cash used in investing activities		(69,677,022	)		-			-			-			-			(69,677,022	)

Cash flows from financing activities:
Payments on inventory facility, net		(265,422	)		-			-			-			-			(265,422	)
Proceeds from factoring liability		121,488,045			-			-			-			-			121,488,045
Payments on factoring liability		(122,844,562	)		-			-			-			-			(122,844,562	)
Payments on assumed debt from Gemini		(50,000,000	)		-			-			-			-			(50,000,000	)
Payments on note payable - related party		(625,147	)		-			-			-			-			(625,147	)
Payments on insurance premium note payment		(2,208,369	)		-			-			-			-			(2,208,369	)
Payments on note payable		(4,000,000	)		-			-			-			-			(4,000,000	)
Sale of preferred stock		35,000,000			-			-			-			-			35,000,000
Common stock issued for exercised warrants		943,907			-			-			-			-			943,907
Common stock issuance costs		(3,199,922	)		-			3,199,922			-			-			-
Preferred stock issuance costs		-			-			(2,113,550	)		-			-			(2,113,550	)
Preferred stock dividends paid		(2,524,087	)		-			-			-			-			(2,524,087	)
Net cash used in financing activities		(28,235,557	)		-			1,086,372			-			-			(27,149,185	)

Net increase/(decrease) in cash		(95,059,996	)		-			-			-			-			(95,059,996	)
Cash, beginning of period		118,341,471			-			-			-			-			118,341,471
Restricted cash, beginning of period		-			-			-			-			-			-
Cash and restricted cash, end of period	$	23,281,475		$	-		$	-		$	-		$	-		$	23,281,475
Restricted cash, end of period	$	-		$	-		$	-		$	-		$	-		$	-
Cash, end of period	$	23,281,475		$	-		$	-		$	-		$	-		$	23,281,475